Skip to main content
. 2024 Nov 19;12:1412934. doi: 10.3389/fpubh.2024.1412934

Table 2.

Comorbid diagnoses by self-reported EQ-5D-5L health dimensions (n = 358).

Comorbidities Total n (%) Mobility Self-care Usual activities Pain/discomfort Anxiety/depression
No problems 291 (82.0) Any problem 64 (18.0) No problems 336 (94.6) Any problem 19 (5.4) No problems 307 (86.5) Any problem 48 (13.5) No problems 166 (46.8) Any problem 189 (53.2) No problems 86 (24.2) Any problem 269 (75.8)
Mental health disorders
No 263 (73.5) 209 (71.8) 51 (79.7) 242 (72.0) 18 (94.7) 218 (71.0) 42 (87.5) 115 (69.3) 145 (76.7) 54 (62.8) 206 (76.6)
Yes 95 (26.5) 82 (28.2) 13 (20.3) 94 (28.0) 1 (5.3) 89 (29.0) 6 (12.5) 51 (30.7) 44 (23.3) 32 (37.2) 63 (23.4)
Respiratory disorders
No 264 (73.7) 222 (76.3) 40 (62.5) 252 (75.0) 10 (52.6) 235 (76.5) 27 (56.2) 130 (78.3) 132 (69.8) 72 (83.7) 190 (70.6)
Yes 94 (26.3) 69 (23.7) 24 (37.5) 84 (25.0) 9 (47.4) 72 (23.5) 21 (43.8) 36 (21.7) 57 (30.2) 14 (16.3) 79 (29.4)
Neurological disorders
No 289 (80.7) 241 (82.8) 45 (70.3) 272 (81.0) 14 (73.7) 253 (82.4) 33 (68.8) 150 (90.4) 136 (72.0) 78 (90.7) 208 (77.3)
Yes 69 (19.3) 50 (17.2) 19 (29.7) 64 (19.0) 5 (26.3) 54 (17.6) 15 (31.2) 16 (9.6) 53 (28.0) 8 (9.3) 61 (22.7)
Cardiovascular disorders
No 293 (81.8) 245 (84.2) 46 (71.9) 278 (82.) 13 (68.4) 260 (84.7) 31 (64.6) 147 (88.5) 144 (76.2) 74 (86.0) 217 (80.7)
Yes 65 (18.2) 46 (15.8) 18 (28.1) 58 (17.3) 6 (31.6) 47 (15.3) 17 (35.4) 19 (11.5) 45 (23.8) 12 (14.0) 52 (19.3)
Endocrine disorders
No 334 (93.3) 277 (95.2) 55 (85.9) 316 (94.0) 16 (84.2) 291 (94.8) 41 (85.4) 161 (97.0) 171 (90.5) 82 (95.3) 250 (92.4)
Yes 24 (6.7) 14 (4.8) 9 (14.1) 20 (6.0) 3 (15.8) 16 (5.2) 7 (14.6) 5 (3.0) 18 (9.5) 4 (4.7) 19 (7.1)
Musculoskeletal disorders
No 297 (83.0) 250 (85.9) 44 (68.7) 281 (83.6) 13 (68.4) 261 (85.0) 33 (68.7) 153 (92.2) 141 (74.6) 73 (84.9) 221 (82.8)
Yes 61 (17.0) 41 (14.1) 20 (31.3) 55 (16.4) 6 (31.6) 46 (15.0) 15 (31.3) 13 (7.8) 48 (25.4) 13 (15.1) 48 (17.8)
Digestive disorders
No 328 (93.3) 270 (92.8) 56 (87.5) 309 (92.0) 17 (89.5) 284 (92.5) 42 (87.5) 156 (94.0) 170 (90.0) 83 (96.5) 243 (90.3)
Yes 30 (6.7) 21 (7.2) 8 (12.5) 27 (8.0) 2 (10.5) 23 (7.5) 6 (12.5) 10 (6.0) 19 (10.0) 3 (3.5) 26 (9.7)
Urogenital disorders
No 334 (93.3) 274 (94.2) 57 (89.1) 315 (93.8) 16 (84.2) 290 (94.5) 41 (85.4) 157 (94.6) 174 (92.1) 83 (96.5) 248 (92.2)
Yes 24 (6.7) 17 (5.8) 7 (10.9) 21 (6.2) 3 (15.8) 17 (5.5) 7 (14.6) 9 (5.4) 15 (7.9) 3 (3.5) 21 (7.8)
Other comorbidities
No 302 (84.4) 252 (86.6) 47 (73.4) 285 (84.8) 14 (73.7) 264 (86.0) 35 (72.9) 148 (89.2) 151 (79.9) 72 (83.7) 227 (83.4)
Yes 56 (15.6) 39 (13.4) 17 (26.6) 51 (15.2) 5 (26.3) 43 (14.0) 13 (27.1) 18 (10.8) 38 (20.1) 14 (16.3) 42 (15.6)
No. of comorbidities
0 96 (26.8) 84 (28.9) 10 (15.6) 90 (26.8) 4 (21.1) 87 (28.3) 7 (14.6) 59 (35.5) 35 (18.5) 24 (27.9) 70 (26.0)
1 121 (33.8) 105 (36.1) 16 (25.0) 117 (34.8) 4 (21.1) 108 (35.2) 13 (27.0) 61 (36.7) 60 (31.7) 38 (44.2) 83 (30.9)
2 74 (20.7) 59 (20.3) 15 (23.4) 71 (21.1) 3 (15.7) 66 (21.5) 8 (16.7) 31 (18.7) 43 (22.8) 15 (17.4) 59 (21.9)
3 or more 67 (18.7) 43 (14.8) 23 (35.9) 58 (17.3) 8 (42.1) 46 (15.0) 20 (41.7) 15 (9.0) 51 (27.0) 9 (10.5) 57 (21.2)

Differences in counts result from missing data. Bolded values indicate statistical significance at p < 0.05.